Godlike Productions - Reply to Thread

Users Online Now: 2,212 (Who's On?)	Visitors Today: 1,130,398
Pageviews Today: 1,576,589	Threads Today: 431	Posts Today: 7,762
12:56 PM

REPLY TO THREAD

Subject Drug company found guilty of negligence and malice. PROOF!! we all were right about drug companies!!

User Name

Font color: Font:

In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.

Original Message The JUDGEMENT is descending on the fallen ones.

Merck found liable in VIOXX Trial

This is major news being announced from Texas this afternoon. The jury deliberated for 10 hours to reach the decision that Merck is liable for the death of the man who died as a result of taking VIOXX. They found Merck guilty of negligence and malice. It has been mentioned repeatedly that this case was weak and not the strongest of the VIOXX cases. Many are speculating that the information that was allowed by the Coroner is what helped the jury decide the case.

Currently there are over four thousand cases awaiting trial against Merck in relation to VIOXX. In the coming days those case numbers could double! Legal analysts are predicting settlements from Merck on many of the pending cases.

The huge jury award to a plaintiff in the nation´s first Vioxx case is likely to inspire thousands more suits on top of the 4,200 already filed against the drug´s marker Merck Co. and push liability estimates that reach $18 billion even higher, analysts said.
Merck Co.´s stock sank $2.35, or 7.7 percent, to close at $28.06. The jury awarded $253.4 million in damages to a widow of a man who died in 2001 of heart arrhythmia, or irregular heart beat, after taking Vioxx for around eight months. The company plans to appeal.
Merck yanked the popular pain reliever from the market last September after a study found it doubled patients´ risks of heart attacks and strokes after 18 months.

Pictures (click to insert)





\| Next Page >>